Nomura Holdings Inc Ptc Therapeutics, Inc. Transaction History

Nomura Holdings Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $612,892 - $797,325	-16,150 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $241,019 - $354,938	5,150 Added 46.82%	16,150 $765,000
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $499,509 - $627,770	11,000 New	11,000 $513,000
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $1.92 Million - $2.47 Million	-45,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $1.24 Million - $2.28 Million	38,450 Added 587.02%	45,000 $2 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $221,521 - $315,513	6,550 New	6,550 $212,000
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $849,548 - $1.08 Million	-23,985 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$28.09 - $39.49 $170,337 - $239,467	-6,064 Reduced 20.18%	23,985 $912,000
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $67,475 - $105,205	2,262 Added 8.14%	30,049 $1.03 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $161,262 - $227,241	4,757 Added 20.66%	27,787 $1.29 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $591,871 - $1.1 Million	23,030 New	23,030 $778,000

220

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.14B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.